|
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
SNP309 T alleles were associated with a significantly decreased prostate cancer risk among Pro72Arg Pro </span>alleles carriers (OR=0.79, 95% CI, 0.64-0.98).
|
26025918 |
2016 |
|
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
SNP309 T alleles were associated with a significantly decreased prostate cancer risk among Pro72Arg Pro </span>alleles carriers (OR=0.79, 95% CI, 0.64-0.98).
|
26025918 |
2016 |
|
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
SNP309 T alleles were associated with a significantly decreased prostate cancer risk among Pro72Arg Pro </span>alleles carriers (OR=0.79, 95% CI, 0.64-0.98).
|
26025918 |
2016 |
|
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
|
25213701 |
2014 |
|
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
|
25213701 |
2014 |
|
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
|
25213701 |
2014 |
|
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Our study provided evidence that the P53 intron 6 G>A and R72P G>C polymorphisms were associated with a higher risk of prostate cancer in a Northern Indian population.
|
21565625 |
2011 |
|
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
This study shows that the overall risk of prostate cancer was not associated with Arg72Pro SNP and HPV infection in our cohort.
|
21778786 |
2011 |
|
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
This study shows that the overall risk of prostate cancer was not associated with Arg72Pro SNP and HPV infection in our cohort.
|
21778786 |
2011 |
|
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Our study provided evidence that the P53 intron 6 G>A and R72P G>C polymorphisms were associated with a higher risk of prostate cancer in a Northern Indian population.
|
21565625 |
2011 |
|
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Our study provided evidence that the P53 intron 6 G>A and R72P G>C polymorphisms were associated with a higher risk of prostate cancer in a Northern Indian population.
|
21565625 |
2011 |
|
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
This study shows that the overall risk of prostate cancer was not associated with Arg72Pro SNP and HPV infection in our cohort.
|
21778786 |
2011 |
|
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
|
20593380 |
2010 |
|
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
|
20593380 |
2010 |
|
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
|
20593380 |
2010 |
|
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
|
17785557 |
2007 |
|
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
|
17785557 |
2007 |
|
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
|
17785557 |
2007 |
|
rs138983188
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Silencing of CD24 enhanced restoration of PRIMA-1-induced mutant p53 in endogenous TP53(P223L/V274F) DU145 cells and in PC3 cells transfected with TP53(R273H) CONCLUSIONS: In human prostate cancers, there is CD24-dependent inactivation of mutant p53.
|
26712693 |
2016 |
|
rs138983188
|
|
|
0.030 |
GeneticVariation |
BEFREE |
These results provide first evidence to implicate the functional Pro64His variant of galectin-3 (LGALS3) in the genetic susceptibility towards prostate cancer.
|
21396839 |
2013 |
|
rs138983188
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Id4 was over-expressed in prostate cancer cell line DU145 harboring mutant p53 (P223L and V274F) and silenced in LNCaP cells with wild type p53.
|
24330748 |
2013 |
|
rs1057520005
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Silencing of CD24 enhanced restoration of PRIMA-1-induced mutant p53 in endogenous TP53(P223L/V274F) DU145 cells and in PC3 cells transfected with TP53(R273H) CONCLUSIONS: In human prostate cancers, there is CD24-dependent inactivation of mutant p53.
|
26712693 |
2016 |
|
rs1057520005
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Id4 was over-expressed in prostate cancer cell line DU145 harboring mutant p53 (P223L and V274F) and silenced in LNCaP cells with wild type p53.
|
24330748 |
2013 |
|
rs1060501201
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We identified 101 heterozygous carriers of G84E who underwent radical prostatectomy for prostate cancer between 1985 and 2011 and matched these men by race, age and tumor grade to 99 HOXB13 wild-type controls.
|
28186998 |
2017 |
|
rs28934576
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Silencing of CD24 enhanced restoration of PRIMA-1-induced mutant p53 in endogenous TP53(P223L/V274F) DU145 cells and in PC3 cells transfected with TP53(R273H) CONCLUSIONS: In human prostate cancers, there is CD24-dependent inactivation of mutant p53.
|
26712693 |
2016 |